Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?

Caggiu E, Paulus K, Arru G, Piredda R, Sechi GP, Sechi LA.

J Neuroimmunol. 2016 Feb 15;291:110-4. doi: 10.1016/j.jneuroim.2016.01.007.

PMID:
26857504
2.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64.

PMID:
16000336
3.

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.

Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ; Netherlands Brain Bank., Rozemuller AJ, van de Berg WD.

Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952.

PMID:
24996051
4.

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

Yanamandra K, Gruden MA, Casaite V, Meskys R, Forsgren L, Morozova-Roche LA.

PLoS One. 2011 Apr 25;6(4):e18513. doi: 10.1371/journal.pone.0018513.

5.

Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.

Garcia-Esparcia P, Hernández-Ortega K, Koneti A, Gil L, Delgado-Morales R, Castaño E, Carmona M, Ferrer I.

Acta Neuropathol Commun. 2015 Dec 1;3:76. doi: 10.1186/s40478-015-0257-4.

6.

Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.

Gründemann J, Schlaudraff F, Haeckel O, Liss B.

Nucleic Acids Res. 2008 Apr;36(7):e38. doi: 10.1093/nar/gkn084.

7.

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.

Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH.

Mov Disord. 2012 May;27(6):709-15. doi: 10.1002/mds.23838.

PMID:
21766334
8.

Alteration in alpha-synuclein mRNA expression in Parkinson's disease.

Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.

Mov Disord. 2004 Feb;19(2):162-70.

PMID:
14978671
9.

α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease.

Chu Y, Mickiewicz AL, Kordower JH.

Neurobiol Dis. 2011 Jan;41(1):71-82. doi: 10.1016/j.nbd.2010.08.022.

PMID:
20816781
11.

rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.

Oliveras-Salvá M, Van der Perren A, Casadei N, Stroobants S, Nuber S, D'Hooge R, Van den Haute C, Baekelandt V.

Mol Neurodegener. 2013 Nov 25;8:44. doi: 10.1186/1750-1326-8-44.

12.

Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.

Doorn KJ, Moors T, Drukarch B, van de Berg WDj, Lucassen PJ, van Dam AM.

Acta Neuropathol Commun. 2014 Aug 7;2:90. doi: 10.1186/s40478-014-0090-1.

13.

Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE.

Mov Disord. 1999 May;14(3):417-22.

PMID:
10348463
14.

Heat shock protein 70 reduces α-synuclein-induced predegenerative neuronal dystrophy in the α-synuclein viral gene transfer rat model of Parkinson's disease.

Moloney TC, Hyland R, O'Toole D, Paucard A, Kirik D, O'Doherty A, Gorman AM, Dowd E.

CNS Neurosci Ther. 2014 Jan;20(1):50-8. doi: 10.1111/cns.12200.

PMID:
24279716
15.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282.

PMID:
19903734
16.

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.

Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH.

Mol Psychiatry. 1998 Nov;3(6):493-9. Erratum in: Mol Psychiatry 1999 Mar;4(2):197.

PMID:
9857974
17.

Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.

Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ.

Glycobiology. 2005 Dec;15(12):1320-31.

PMID:
16037493
18.

Nigral burden of alpha-synuclein correlates with striatal dopamine deficit.

Kovacs GG, Milenkovic IJ, Preusser M, Budka H.

Mov Disord. 2008 Aug 15;23(11):1608-12. doi: 10.1002/mds.22207.

PMID:
18649394
19.

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Ferrer I, Martinez A, Blanco R, Dalfó E, Carmona M.

J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Review.

PMID:
20862500
20.

Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?

Arru G, Caggiu E, Paulus K, Sechi GP, Mameli G, Sechi LA.

J Neuroimmunol. 2016 Apr 15;293:86-90. doi: 10.1016/j.jneuroim.2016.02.016.

PMID:
27049567
Items per page

Supplemental Content

Support Center